Medical Care
Global Hepatitis C Virus (HCV) Antiviral Market Research Report 2025
- Sep 06, 25
- ID: 492606
- Pages: 89
- Figures: 85
- Views: 3
This report aims to provide a comprehensive presentation of the global market for Hepatitis C Virus (HCV) Antiviral, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis C Virus (HCV) Antiviral.
The Hepatitis C Virus (HCV) Antiviral market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hepatitis C Virus (HCV) Antiviral market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis C Virus (HCV) Antiviral companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Abbott
Siemens
Qiagen
bioMérieux
Bio-Rad Laboratories
Meridian Bioscience
Vista Diagnostics
Biogate Laboratories
J.Mitra & Co. Ltd
Siemens Medical
General Biologicals
Segment by Type
HCV Antibody
HCV Viral Load
HCV Genotyping
Segment by Application
Diagnostic Centers
Hospitals
Home Use
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hepatitis C Virus (HCV) Antiviral company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Hepatitis C Virus (HCV) Antiviral market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hepatitis C Virus (HCV) Antiviral market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis C Virus (HCV) Antiviral companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Abbott
Siemens
Qiagen
bioMérieux
Bio-Rad Laboratories
Meridian Bioscience
Vista Diagnostics
Biogate Laboratories
J.Mitra & Co. Ltd
Siemens Medical
General Biologicals
Segment by Type
HCV Antibody
HCV Viral Load
HCV Genotyping
Segment by Application
Diagnostic Centers
Hospitals
Home Use
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hepatitis C Virus (HCV) Antiviral company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 HCV Antibody
1.2.3 HCV Viral Load
1.2.4 HCV Genotyping
1.3 Market by Application
1.3.1 Global Hepatitis C Virus (HCV) Antiviral Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Centers
1.3.3 Hospitals
1.3.4 Home Use
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis C Virus (HCV) Antiviral Market Perspective (2020-2031)
2.2 Global Hepatitis C Virus (HCV) Antiviral Growth Trends by Region
2.2.1 Global Hepatitis C Virus (HCV) Antiviral Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hepatitis C Virus (HCV) Antiviral Historic Market Size by Region (2020-2025)
2.2.3 Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Region (2026-2031)
2.3 Hepatitis C Virus (HCV) Antiviral Market Dynamics
2.3.1 Hepatitis C Virus (HCV) Antiviral Industry Trends
2.3.2 Hepatitis C Virus (HCV) Antiviral Market Drivers
2.3.3 Hepatitis C Virus (HCV) Antiviral Market Challenges
2.3.4 Hepatitis C Virus (HCV) Antiviral Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis C Virus (HCV) Antiviral Players by Revenue
3.1.1 Global Top Hepatitis C Virus (HCV) Antiviral Players by Revenue (2020-2025)
3.1.2 Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Players (2020-2025)
3.2 Global Hepatitis C Virus (HCV) Antiviral Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hepatitis C Virus (HCV) Antiviral Revenue
3.4 Global Hepatitis C Virus (HCV) Antiviral Market Concentration Ratio
3.4.1 Global Hepatitis C Virus (HCV) Antiviral Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Virus (HCV) Antiviral Revenue in 2024
3.5 Global Key Players of Hepatitis C Virus (HCV) Antiviral Head office and Area Served
3.6 Global Key Players of Hepatitis C Virus (HCV) Antiviral, Product and Application
3.7 Global Key Players of Hepatitis C Virus (HCV) Antiviral, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis C Virus (HCV) Antiviral Breakdown Data by Type
4.1 Global Hepatitis C Virus (HCV) Antiviral Historic Market Size by Type (2020-2025)
4.2 Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Type (2026-2031)
5 Hepatitis C Virus (HCV) Antiviral Breakdown Data by Application
5.1 Global Hepatitis C Virus (HCV) Antiviral Historic Market Size by Application (2020-2025)
5.2 Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hepatitis C Virus (HCV) Antiviral Market Size (2020-2031)
6.2 North America Hepatitis C Virus (HCV) Antiviral Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025)
6.4 North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hepatitis C Virus (HCV) Antiviral Market Size (2020-2031)
7.2 Europe Hepatitis C Virus (HCV) Antiviral Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025)
7.4 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size (2020-2031)
8.2 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region (2020-2025)
8.4 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hepatitis C Virus (HCV) Antiviral Market Size (2020-2031)
9.2 Latin America Hepatitis C Virus (HCV) Antiviral Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025)
9.4 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size (2020-2031)
10.2 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025)
10.4 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Introduction
11.1.4 Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Hepatitis C Virus (HCV) Antiviral Introduction
11.2.4 Abbott Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Hepatitis C Virus (HCV) Antiviral Introduction
11.3.4 Siemens Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.3.5 Siemens Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Details
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Hepatitis C Virus (HCV) Antiviral Introduction
11.4.4 Qiagen Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.4.5 Qiagen Recent Development
11.5 bioMérieux
11.5.1 bioMérieux Company Details
11.5.2 bioMérieux Business Overview
11.5.3 bioMérieux Hepatitis C Virus (HCV) Antiviral Introduction
11.5.4 bioMérieux Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.5.5 bioMérieux Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Introduction
11.6.4 Bio-Rad Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Meridian Bioscience
11.7.1 Meridian Bioscience Company Details
11.7.2 Meridian Bioscience Business Overview
11.7.3 Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Introduction
11.7.4 Meridian Bioscience Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.7.5 Meridian Bioscience Recent Development
11.8 Vista Diagnostics
11.8.1 Vista Diagnostics Company Details
11.8.2 Vista Diagnostics Business Overview
11.8.3 Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Introduction
11.8.4 Vista Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.8.5 Vista Diagnostics Recent Development
11.9 Biogate Laboratories
11.9.1 Biogate Laboratories Company Details
11.9.2 Biogate Laboratories Business Overview
11.9.3 Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Introduction
11.9.4 Biogate Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.9.5 Biogate Laboratories Recent Development
11.10 J.Mitra & Co. Ltd
11.10.1 J.Mitra & Co. Ltd Company Details
11.10.2 J.Mitra & Co. Ltd Business Overview
11.10.3 J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Introduction
11.10.4 J.Mitra & Co. Ltd Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.10.5 J.Mitra & Co. Ltd Recent Development
11.11 Siemens Medical
11.11.1 Siemens Medical Company Details
11.11.2 Siemens Medical Business Overview
11.11.3 Siemens Medical Hepatitis C Virus (HCV) Antiviral Introduction
11.11.4 Siemens Medical Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.11.5 Siemens Medical Recent Development
11.12 General Biologicals
11.12.1 General Biologicals Company Details
11.12.2 General Biologicals Business Overview
11.12.3 General Biologicals Hepatitis C Virus (HCV) Antiviral Introduction
11.12.4 General Biologicals Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.12.5 General Biologicals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 HCV Antibody
1.2.3 HCV Viral Load
1.2.4 HCV Genotyping
1.3 Market by Application
1.3.1 Global Hepatitis C Virus (HCV) Antiviral Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Centers
1.3.3 Hospitals
1.3.4 Home Use
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis C Virus (HCV) Antiviral Market Perspective (2020-2031)
2.2 Global Hepatitis C Virus (HCV) Antiviral Growth Trends by Region
2.2.1 Global Hepatitis C Virus (HCV) Antiviral Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hepatitis C Virus (HCV) Antiviral Historic Market Size by Region (2020-2025)
2.2.3 Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Region (2026-2031)
2.3 Hepatitis C Virus (HCV) Antiviral Market Dynamics
2.3.1 Hepatitis C Virus (HCV) Antiviral Industry Trends
2.3.2 Hepatitis C Virus (HCV) Antiviral Market Drivers
2.3.3 Hepatitis C Virus (HCV) Antiviral Market Challenges
2.3.4 Hepatitis C Virus (HCV) Antiviral Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis C Virus (HCV) Antiviral Players by Revenue
3.1.1 Global Top Hepatitis C Virus (HCV) Antiviral Players by Revenue (2020-2025)
3.1.2 Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Players (2020-2025)
3.2 Global Hepatitis C Virus (HCV) Antiviral Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hepatitis C Virus (HCV) Antiviral Revenue
3.4 Global Hepatitis C Virus (HCV) Antiviral Market Concentration Ratio
3.4.1 Global Hepatitis C Virus (HCV) Antiviral Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Virus (HCV) Antiviral Revenue in 2024
3.5 Global Key Players of Hepatitis C Virus (HCV) Antiviral Head office and Area Served
3.6 Global Key Players of Hepatitis C Virus (HCV) Antiviral, Product and Application
3.7 Global Key Players of Hepatitis C Virus (HCV) Antiviral, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis C Virus (HCV) Antiviral Breakdown Data by Type
4.1 Global Hepatitis C Virus (HCV) Antiviral Historic Market Size by Type (2020-2025)
4.2 Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Type (2026-2031)
5 Hepatitis C Virus (HCV) Antiviral Breakdown Data by Application
5.1 Global Hepatitis C Virus (HCV) Antiviral Historic Market Size by Application (2020-2025)
5.2 Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hepatitis C Virus (HCV) Antiviral Market Size (2020-2031)
6.2 North America Hepatitis C Virus (HCV) Antiviral Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025)
6.4 North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hepatitis C Virus (HCV) Antiviral Market Size (2020-2031)
7.2 Europe Hepatitis C Virus (HCV) Antiviral Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025)
7.4 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size (2020-2031)
8.2 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region (2020-2025)
8.4 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hepatitis C Virus (HCV) Antiviral Market Size (2020-2031)
9.2 Latin America Hepatitis C Virus (HCV) Antiviral Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025)
9.4 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size (2020-2031)
10.2 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025)
10.4 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Introduction
11.1.4 Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Hepatitis C Virus (HCV) Antiviral Introduction
11.2.4 Abbott Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Hepatitis C Virus (HCV) Antiviral Introduction
11.3.4 Siemens Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.3.5 Siemens Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Details
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Hepatitis C Virus (HCV) Antiviral Introduction
11.4.4 Qiagen Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.4.5 Qiagen Recent Development
11.5 bioMérieux
11.5.1 bioMérieux Company Details
11.5.2 bioMérieux Business Overview
11.5.3 bioMérieux Hepatitis C Virus (HCV) Antiviral Introduction
11.5.4 bioMérieux Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.5.5 bioMérieux Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Introduction
11.6.4 Bio-Rad Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Meridian Bioscience
11.7.1 Meridian Bioscience Company Details
11.7.2 Meridian Bioscience Business Overview
11.7.3 Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Introduction
11.7.4 Meridian Bioscience Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.7.5 Meridian Bioscience Recent Development
11.8 Vista Diagnostics
11.8.1 Vista Diagnostics Company Details
11.8.2 Vista Diagnostics Business Overview
11.8.3 Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Introduction
11.8.4 Vista Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.8.5 Vista Diagnostics Recent Development
11.9 Biogate Laboratories
11.9.1 Biogate Laboratories Company Details
11.9.2 Biogate Laboratories Business Overview
11.9.3 Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Introduction
11.9.4 Biogate Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.9.5 Biogate Laboratories Recent Development
11.10 J.Mitra & Co. Ltd
11.10.1 J.Mitra & Co. Ltd Company Details
11.10.2 J.Mitra & Co. Ltd Business Overview
11.10.3 J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Introduction
11.10.4 J.Mitra & Co. Ltd Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.10.5 J.Mitra & Co. Ltd Recent Development
11.11 Siemens Medical
11.11.1 Siemens Medical Company Details
11.11.2 Siemens Medical Business Overview
11.11.3 Siemens Medical Hepatitis C Virus (HCV) Antiviral Introduction
11.11.4 Siemens Medical Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.11.5 Siemens Medical Recent Development
11.12 General Biologicals
11.12.1 General Biologicals Company Details
11.12.2 General Biologicals Business Overview
11.12.3 General Biologicals Hepatitis C Virus (HCV) Antiviral Introduction
11.12.4 General Biologicals Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
11.12.5 General Biologicals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of HCV Antibody
Table 3. Key Players of HCV Viral Load
Table 4. Key Players of HCV Genotyping
Table 5. Global Hepatitis C Virus (HCV) Antiviral Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Hepatitis C Virus (HCV) Antiviral Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Hepatitis C Virus (HCV) Antiviral Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Hepatitis C Virus (HCV) Antiviral Market Share by Region (2020-2025)
Table 9. Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Hepatitis C Virus (HCV) Antiviral Market Share by Region (2026-2031)
Table 11. Hepatitis C Virus (HCV) Antiviral Market Trends
Table 12. Hepatitis C Virus (HCV) Antiviral Market Drivers
Table 13. Hepatitis C Virus (HCV) Antiviral Market Challenges
Table 14. Hepatitis C Virus (HCV) Antiviral Market Restraints
Table 15. Global Hepatitis C Virus (HCV) Antiviral Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Hepatitis C Virus (HCV) Antiviral Market Share by Players (2020-2025)
Table 17. Global Top Hepatitis C Virus (HCV) Antiviral Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Virus (HCV) Antiviral as of 2024)
Table 18. Ranking of Global Top Hepatitis C Virus (HCV) Antiviral Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Hepatitis C Virus (HCV) Antiviral Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Hepatitis C Virus (HCV) Antiviral, Headquarters and Area Served
Table 21. Global Key Players of Hepatitis C Virus (HCV) Antiviral, Product and Application
Table 22. Global Key Players of Hepatitis C Virus (HCV) Antiviral, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hepatitis C Virus (HCV) Antiviral Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Type (2020-2025)
Table 26. Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Type (2026-2031)
Table 28. Global Hepatitis C Virus (HCV) Antiviral Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Application (2020-2025)
Table 30. Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Application (2026-2031)
Table 32. North America Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031) & (US$ Million)
Table 47. Roche Diagnostics Company Details
Table 48. Roche Diagnostics Business Overview
Table 49. Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Product
Table 50. Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 51. Roche Diagnostics Recent Development
Table 52. Abbott Company Details
Table 53. Abbott Business Overview
Table 54. Abbott Hepatitis C Virus (HCV) Antiviral Product
Table 55. Abbott Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 56. Abbott Recent Development
Table 57. Siemens Company Details
Table 58. Siemens Business Overview
Table 59. Siemens Hepatitis C Virus (HCV) Antiviral Product
Table 60. Siemens Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 61. Siemens Recent Development
Table 62. Qiagen Company Details
Table 63. Qiagen Business Overview
Table 64. Qiagen Hepatitis C Virus (HCV) Antiviral Product
Table 65. Qiagen Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 66. Qiagen Recent Development
Table 67. bioMérieux Company Details
Table 68. bioMérieux Business Overview
Table 69. bioMérieux Hepatitis C Virus (HCV) Antiviral Product
Table 70. bioMérieux Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 71. bioMérieux Recent Development
Table 72. Bio-Rad Laboratories Company Details
Table 73. Bio-Rad Laboratories Business Overview
Table 74. Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Product
Table 75. Bio-Rad Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 76. Bio-Rad Laboratories Recent Development
Table 77. Meridian Bioscience Company Details
Table 78. Meridian Bioscience Business Overview
Table 79. Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Product
Table 80. Meridian Bioscience Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 81. Meridian Bioscience Recent Development
Table 82. Vista Diagnostics Company Details
Table 83. Vista Diagnostics Business Overview
Table 84. Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Product
Table 85. Vista Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 86. Vista Diagnostics Recent Development
Table 87. Biogate Laboratories Company Details
Table 88. Biogate Laboratories Business Overview
Table 89. Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Product
Table 90. Biogate Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 91. Biogate Laboratories Recent Development
Table 92. J.Mitra & Co. Ltd Company Details
Table 93. J.Mitra & Co. Ltd Business Overview
Table 94. J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Product
Table 95. J.Mitra & Co. Ltd Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 96. J.Mitra & Co. Ltd Recent Development
Table 97. Siemens Medical Company Details
Table 98. Siemens Medical Business Overview
Table 99. Siemens Medical Hepatitis C Virus (HCV) Antiviral Product
Table 100. Siemens Medical Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 101. Siemens Medical Recent Development
Table 102. General Biologicals Company Details
Table 103. General Biologicals Business Overview
Table 104. General Biologicals Hepatitis C Virus (HCV) Antiviral Product
Table 105. General Biologicals Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 106. General Biologicals Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Hepatitis C Virus (HCV) Antiviral Picture
Figure 2. Global Hepatitis C Virus (HCV) Antiviral Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hepatitis C Virus (HCV) Antiviral Market Share by Type: 2024 VS 2031
Figure 4. HCV Antibody Features
Figure 5. HCV Viral Load Features
Figure 6. HCV Genotyping Features
Figure 7. Global Hepatitis C Virus (HCV) Antiviral Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Hepatitis C Virus (HCV) Antiviral Market Share by Application: 2024 VS 2031
Figure 9. Diagnostic Centers Case Studies
Figure 10. Hospitals Case Studies
Figure 11. Home Use Case Studies
Figure 12. Hepatitis C Virus (HCV) Antiviral Report Years Considered
Figure 13. Global Hepatitis C Virus (HCV) Antiviral Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Hepatitis C Virus (HCV) Antiviral Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Hepatitis C Virus (HCV) Antiviral Market Share by Region: 2024 VS 2031
Figure 16. Global Hepatitis C Virus (HCV) Antiviral Market Share by Players in 2024
Figure 17. Global Top Hepatitis C Virus (HCV) Antiviral Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Virus (HCV) Antiviral as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Hepatitis C Virus (HCV) Antiviral Revenue in 2024
Figure 19. North America Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Hepatitis C Virus (HCV) Antiviral Market Share by Country (2020-2031)
Figure 21. United States Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Hepatitis C Virus (HCV) Antiviral Market Share by Country (2020-2031)
Figure 25. Germany Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Share by Region (2020-2031)
Figure 33. China Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Hepatitis C Virus (HCV) Antiviral Market Share by Country (2020-2031)
Figure 41. Mexico Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Share by Country (2020-2031)
Figure 45. Turkey Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Roche Diagnostics Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 49. Abbott Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 50. Siemens Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 51. Qiagen Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 52. bioMérieux Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 54. Meridian Bioscience Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 55. Vista Diagnostics Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 56. Biogate Laboratories Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 57. J.Mitra & Co. Ltd Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 58. Siemens Medical Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 59. General Biologicals Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of HCV Antibody
Table 3. Key Players of HCV Viral Load
Table 4. Key Players of HCV Genotyping
Table 5. Global Hepatitis C Virus (HCV) Antiviral Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Hepatitis C Virus (HCV) Antiviral Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Hepatitis C Virus (HCV) Antiviral Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Hepatitis C Virus (HCV) Antiviral Market Share by Region (2020-2025)
Table 9. Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Hepatitis C Virus (HCV) Antiviral Market Share by Region (2026-2031)
Table 11. Hepatitis C Virus (HCV) Antiviral Market Trends
Table 12. Hepatitis C Virus (HCV) Antiviral Market Drivers
Table 13. Hepatitis C Virus (HCV) Antiviral Market Challenges
Table 14. Hepatitis C Virus (HCV) Antiviral Market Restraints
Table 15. Global Hepatitis C Virus (HCV) Antiviral Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Hepatitis C Virus (HCV) Antiviral Market Share by Players (2020-2025)
Table 17. Global Top Hepatitis C Virus (HCV) Antiviral Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Virus (HCV) Antiviral as of 2024)
Table 18. Ranking of Global Top Hepatitis C Virus (HCV) Antiviral Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Hepatitis C Virus (HCV) Antiviral Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Hepatitis C Virus (HCV) Antiviral, Headquarters and Area Served
Table 21. Global Key Players of Hepatitis C Virus (HCV) Antiviral, Product and Application
Table 22. Global Key Players of Hepatitis C Virus (HCV) Antiviral, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hepatitis C Virus (HCV) Antiviral Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Type (2020-2025)
Table 26. Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Type (2026-2031)
Table 28. Global Hepatitis C Virus (HCV) Antiviral Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Application (2020-2025)
Table 30. Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Application (2026-2031)
Table 32. North America Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2026-2031) & (US$ Million)
Table 47. Roche Diagnostics Company Details
Table 48. Roche Diagnostics Business Overview
Table 49. Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Product
Table 50. Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 51. Roche Diagnostics Recent Development
Table 52. Abbott Company Details
Table 53. Abbott Business Overview
Table 54. Abbott Hepatitis C Virus (HCV) Antiviral Product
Table 55. Abbott Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 56. Abbott Recent Development
Table 57. Siemens Company Details
Table 58. Siemens Business Overview
Table 59. Siemens Hepatitis C Virus (HCV) Antiviral Product
Table 60. Siemens Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 61. Siemens Recent Development
Table 62. Qiagen Company Details
Table 63. Qiagen Business Overview
Table 64. Qiagen Hepatitis C Virus (HCV) Antiviral Product
Table 65. Qiagen Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 66. Qiagen Recent Development
Table 67. bioMérieux Company Details
Table 68. bioMérieux Business Overview
Table 69. bioMérieux Hepatitis C Virus (HCV) Antiviral Product
Table 70. bioMérieux Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 71. bioMérieux Recent Development
Table 72. Bio-Rad Laboratories Company Details
Table 73. Bio-Rad Laboratories Business Overview
Table 74. Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Product
Table 75. Bio-Rad Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 76. Bio-Rad Laboratories Recent Development
Table 77. Meridian Bioscience Company Details
Table 78. Meridian Bioscience Business Overview
Table 79. Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Product
Table 80. Meridian Bioscience Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 81. Meridian Bioscience Recent Development
Table 82. Vista Diagnostics Company Details
Table 83. Vista Diagnostics Business Overview
Table 84. Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Product
Table 85. Vista Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 86. Vista Diagnostics Recent Development
Table 87. Biogate Laboratories Company Details
Table 88. Biogate Laboratories Business Overview
Table 89. Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Product
Table 90. Biogate Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 91. Biogate Laboratories Recent Development
Table 92. J.Mitra & Co. Ltd Company Details
Table 93. J.Mitra & Co. Ltd Business Overview
Table 94. J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Product
Table 95. J.Mitra & Co. Ltd Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 96. J.Mitra & Co. Ltd Recent Development
Table 97. Siemens Medical Company Details
Table 98. Siemens Medical Business Overview
Table 99. Siemens Medical Hepatitis C Virus (HCV) Antiviral Product
Table 100. Siemens Medical Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 101. Siemens Medical Recent Development
Table 102. General Biologicals Company Details
Table 103. General Biologicals Business Overview
Table 104. General Biologicals Hepatitis C Virus (HCV) Antiviral Product
Table 105. General Biologicals Revenue in Hepatitis C Virus (HCV) Antiviral Business (2020-2025) & (US$ Million)
Table 106. General Biologicals Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Hepatitis C Virus (HCV) Antiviral Picture
Figure 2. Global Hepatitis C Virus (HCV) Antiviral Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hepatitis C Virus (HCV) Antiviral Market Share by Type: 2024 VS 2031
Figure 4. HCV Antibody Features
Figure 5. HCV Viral Load Features
Figure 6. HCV Genotyping Features
Figure 7. Global Hepatitis C Virus (HCV) Antiviral Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Hepatitis C Virus (HCV) Antiviral Market Share by Application: 2024 VS 2031
Figure 9. Diagnostic Centers Case Studies
Figure 10. Hospitals Case Studies
Figure 11. Home Use Case Studies
Figure 12. Hepatitis C Virus (HCV) Antiviral Report Years Considered
Figure 13. Global Hepatitis C Virus (HCV) Antiviral Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Hepatitis C Virus (HCV) Antiviral Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Hepatitis C Virus (HCV) Antiviral Market Share by Region: 2024 VS 2031
Figure 16. Global Hepatitis C Virus (HCV) Antiviral Market Share by Players in 2024
Figure 17. Global Top Hepatitis C Virus (HCV) Antiviral Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Virus (HCV) Antiviral as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Hepatitis C Virus (HCV) Antiviral Revenue in 2024
Figure 19. North America Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Hepatitis C Virus (HCV) Antiviral Market Share by Country (2020-2031)
Figure 21. United States Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Hepatitis C Virus (HCV) Antiviral Market Share by Country (2020-2031)
Figure 25. Germany Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Share by Region (2020-2031)
Figure 33. China Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Hepatitis C Virus (HCV) Antiviral Market Share by Country (2020-2031)
Figure 41. Mexico Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Share by Country (2020-2031)
Figure 45. Turkey Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Roche Diagnostics Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 49. Abbott Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 50. Siemens Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 51. Qiagen Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 52. bioMérieux Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 54. Meridian Bioscience Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 55. Vista Diagnostics Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 56. Biogate Laboratories Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 57. J.Mitra & Co. Ltd Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 58. Siemens Medical Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 59. General Biologicals Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232